Lantern Pharma Inc.

NASDAQ:LTRN

4.2 (USD) • At close September 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -20.781-15.962-14.26-12.363-5.908-2.428-1.726
Depreciation & Amortization 0.0170.0150.010.0070.0030.002-0.003
Deferred Income Tax 0000.113-1.0820.2520
Stock Based Compensation 0.7331.0681.1880.9621.1920.1180.186
Change In Working Capital 2.2280.538-0.6120.6-0.9390.1810.272
Accounts Receivables -0.176-0.159-0.158-0.072000.187
Inventory 0000000
Accounts Payables 1.636-0.2360.581.6220.1170.3730.07
Other Working Capital 0.7670.933-1.034-0.95-1.056-0.1920.272
Other Non Cash Items -0.01-0.0050.9060.0911.082-0.252-0.076
Operating Cash Flow -17.813-14.347-12.767-10.592-5.652-2.128-1.272
Investing Activities:
Investments In Property Plant And Equipment -0.013-0.019-0.028-0.015-0.016-0.0060
Acquisitions Net 00-179.26819,530.586000.005
Purchases Of Investments -17.276-8.196-3.913-19.579000
Sales Maturities Of Investments 20.6587.2854.120.064000
Other Investing Activites 00179.268-19,530.586000.005
Investing Cash Flow 3.369-0.930.179-19.531-0.016-0.0060.005
Financing Activities:
Debt Repayment 00000.10900
Common Stock Issued 0.06700.364.35626.252.9210
Common Stock Repurchased 0-0.5-2.482-0.94000
Dividends Paid 0000000
Other Financing Activities 000-5.584-02.9210.535
Financing Cash Flow 0.067-0.5-2.18263.41623.6652.9210.535
Other Information:
Effect Of Forex Changes On Cash -0.05-0.0280.9890.001000
Net Change In Cash -14.427-15.805-13.78133.29517.9970.787-0.731
Cash At End Of Period 7.51121.93837.74352.52419.2291.2320.445